+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Novartis AG - logo

Novartis is a global healthcare company based in Basel, Switzerland. They have created a patient-centered portfolio consisting of a wide range of products and treatments to address unmet medical needs. Novartis focuses its business on three leading divisions: pharmaceuticals, eye care and generics. They are expanding their presence in the emerging markets of Asia, Africa and Latin America, where there is fast-growing demand for access to high-quality medicines and healthcare.

Low-Density Lipoprotein Market - Global Forecast 2025-2030 - Product Thumbnail Image

Low-Density Lipoprotein Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 197 Pages
  • Global
From
Recombinant Vaccines Market Report and Forecast 2023-2031 - Product Thumbnail Image

Recombinant Vaccines Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
From
Molecular Diagnostics Global Market Report 2022 - Product Thumbnail Image

Molecular Diagnostics Global Market Report 2022

  • Report
  • September 2022
  • 175 Pages
  • Global
From
Conjugate Vaccine Market Report and Forecast 2023-2031 - Product Thumbnail Image

Conjugate Vaccine Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
Nanoemulsions - Global Strategic Business Report - Product Thumbnail Image

Nanoemulsions - Global Strategic Business Report

  • Report
  • January 2026
  • 193 Pages
  • Global
From
Global Biopharmaceuticals Market Outlook to 2027 - Product Thumbnail Image

Global Biopharmaceuticals Market Outlook to 2027

  • Report
  • July 2023
  • 80 Pages
  • Global
From
Naloxone Market - Global Strategic Business Report - Product Thumbnail Image

Naloxone Market - Global Strategic Business Report

  • Report
  • January 2026
  • 369 Pages
  • Global
From
Cyclooxygenase 1 Inhibitors - Global Strategic Business Report - Product Thumbnail Image

Cyclooxygenase 1 Inhibitors - Global Strategic Business Report

  • Report
  • January 2026
  • 367 Pages
  • Global
From
Strategy At Novartis: Culture Change As The 'How' Behind The 'What' - Product Thumbnail Image

Strategy At Novartis: Culture Change As The 'How' Behind The 'What'

  • Newsletter
  • January 2026
  • 6 Pages
  • Global
From
From
Loading Indicator